Artificial Intelligence is helping to advance drug pipelines (in oncology drug development and beyond) faster and more cost-effectively. Scroll down to see the impactful statistics.
![](https://predictive-oncology.com/wp-content/uploads/2023/02/POAI-Infographic-Post-final.jpg)
A recent proof of concept study demonstrated that the AI-driven PEDAL platform could predict whether or not a drug compound would be a hit for a given tumor sample with 92% accuracy.
Interested in exploring a pilot program leveraging the PEDAL platform? Contact us here.